Next Article in Journal
2-((Pyren-1-ylmethylamino)methyl)quinolin-8-ol
Previous Article in Journal
Trans-dichloro-2,3-naphthalenediamine bis[(2-methoxyethyl)­(diphenyl)phosphine]­ruthenium(II) Complex
Open AccessShort Note

1-Acetyl-17-{2-hydroxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione

Chair and Department of Medical Chemistry, 1st Faculty of Medicine, Medical University of Warsaw, 3 Oczki Street, 02-007 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Molbank 2010, 2010(3), M697; https://doi.org/10.3390/M697
Received: 5 August 2010 / Accepted: 14 September 2010 / Published: 17 September 2010
The title compound was synthesized by condensation of an oxiran imide derivative with an appropriate amine and its IR, 1H NMR, 13C NMR and mass spectroscopic data are reported. The synthesized compound was evaluated for its cytotoxicity and anti-HIV-1 activity in MT-4 cells. View Full-Text
Keywords: 1-acetyl-17-{2-hydroxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione; cytotoxicity 1-acetyl-17-{2-hydroxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione; cytotoxicity
Show Figures

Graphical abstract

MDPI and ACS Style

Pakosińska-Parys, M.; Kossakowski, J.; Struga, M. 1-Acetyl-17-{2-hydroxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione. Molbank 2010, 2010, M697.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop